EPHA4 and synovial sarcoma: Strikingly, we found that in vitro treatment of SS cells or healthy CD4+ T-cells with a general phosphatase inhibitor (pervanadate) could not induce phosphorylation of the EPHA4 kinase domain at Y779, whereas phosphorylation of another kinase, STAT3, was effectively induced in these cells.